Executive Summary
224 corporate events are scheduled for May 29, 2026: 217 financial results and 7 board meetings. Companies on the calendar include A2Z Infra Engineering Limited, Aarey Drugs & Pharmaceuticals Limited, Abhishek Corporation Limited, Aegis Logistics Limited, Agro Phos India Limited, AION-TECH SOLUTIONS LIMITED and 214 others.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India Quarterly Results BSE NSE Announcements digest from May 28, 2026.
Scheduled Events (224)
Companies with corporate events on the calendar for this day.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the quarter and year ended March 31, 2026, and recommendation of Final dividend, if any for FY 2025-26
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and and other business matters.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 29th May 2026, inter alia, to consider the following: 1. Approval of audited standalone financial results of the Company for the quarter and financial year ended 31st March 2026; 2. Approval of audited consolidated financial results of the Company for the quarter and financial year ended 31st March 2026; and 3. Recommendation of final dividend, if any, for the financial year ended 31st March 2026.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Audited Financial Results for the Quarter and Year ended March 31, 2026
The meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended March 31, 2026, Standalone and Consolidated Annual Financial Statements and Auditors' Report thereon, Board's Report (including Management Discussion and Analysis Report), Business Responsibility and Sustainability Report, Report on Corporate Governance, Recommendation of dividend (if any) for the financial year ended March 31, 2026 and the 94th Annual General Meeting of the shareholders of the Company.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
i)Consider and approve the Audited Financial Results (Standalone & Consolidated) ofthe Company for the quarter and year ended March 31, 2026; ii) Consider and recommend final dividend, if any, on the Equity Shares of the Companyfor the financial year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2026.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the Audited Financial Results for the quarter and Financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve Standalone and Consolidated Audited financial results for the period ended March 31, 2026 and to Recommend Final Dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
The meeting of the Board of Directors of the Company is scheduled on 29/05/2026 , inter alia,1. to consider and approve the Audited Standalone and Consolidated Financial Results of the Company under Indian Accounting Standards (IND AS) for the quarter and year ended March 31, 2026. 2. To recommend dividend, if any, on the equity shares for financial year ended March 31, 2026. 3. Any other matter as may be considered appropriate by the Board.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve, inter alia, the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and financial year ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
GUJGASLTD : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 26, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve inter alia, Audited Financial Result and Dividend, subject to Shareholders approval at ensuing Annual General meeting.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
HARDWYN : 29-May-2026 : The Company has informed the Exchange that a due to an inadvertent clerical error during submission to the Exchange, the meeting date was mistakenly selected as May 27, 2026. We hereby clarify that the meeting of the Board of Directors is scheduled for May 29, 2026, inter alia, to consider and approve the financial results for the period ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results (Standalone and Consolidated) for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the audited financial results (Standalone & Consolidated) and audited financial statements (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the audited (standalone & consolidated) Financial Results for the quarter and financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results and recommendation of Final Dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend if any, and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
LOVABLE : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 27, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026
Intimation of Board Meeting scheduled to be held on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) for the 4th Quarter and Financial Year ended March 31, 2026 and to recommend declaration of dividend, if any on the Equity Shares of the Company for the Financial Year 2025-26.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR ")
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the year ended March 31, 2026 and other business matters
MMTC has informed the Exchange that a Board meeting to be held on Thursday, May 28, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on Friday, May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and Final dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026 and Final Dividend, if any, for the Financial Year ended March 31, 2026
MURUDCERA : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 20, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and stock split of equity shares
To consider and approve the Audited financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend if any
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and recommendation of final dividend for FY 2025-26 (if any).
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend, Fund Raising and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the quarter and year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the audited financial results for the year ended March 31, 2026 and recommend a final dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company, for the quarter and financial year ended March 31, 2026.
To consider and approve the audited(Standalone & Consolidated) financial results for the quarter and Financial Year ended March 31, 2026 is scheduled to be held on Friday, 29/05/2026 at 03:15 P.M.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
RUSHIL : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, to consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
Meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2026 to consider and approve the financial results for the period ended March 31, 2026 and recommend dividend for the FY 2025-2026.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Standalone and Consolidated financial results for the period ended March 31, 2026
To consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider review and take note the Consolidated Unaudited financial results for the period ended December 31, 2025
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
SSWL : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 26, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Audited financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited financial results for the quarter and year ended 31st March, 2026 and Recommendation of Final Dividend for the financial year 2025-26.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve Standalone and Consolidated Audited Financial Statements for the quarter and for the year ended March 31, 2026
Board Meeting Intimation for consideration and approval of Audited Financial Results of the Company for the fourth quarter and year ended 31St March, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the audited financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
WANBURY : 29-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 14, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 29, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Annual financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
Source: company filings and exchange event calendars. Times shown in local market time when published.
Get daily alerts with full AI analysis of all 224 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Quarterly Results BSE NSE Announcements
🇮🇳 More from India
View all →June 01, 2026
India Pre-Market Regulatory Roundup — June 01, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India Pre-Market Regulatory Roundup — May 31, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India MCA Corporate Compliance Enforcement — May 31, 2026
India MCA Corporate Compliance Enforcement
May 31, 2026
India RBI Banking Regulatory Enforcement Actions — May 31, 2026
India RBI Banking Regulatory Enforcement Actions